Found 93 matching trials
Study to Assess the Pharmacokinetics of AZD6140 After Single Dose in Healthy Japanese Male Volunteers PHASE1 The purpose of this study is to assess the pharmacokinetics of AZD6140 and ...
Show More Learn More & Join Trial
DIAMOND - Dual Antiplatelet Therapy to Reduce Myocardial Injury PHASE2 Heart attacks are most commonly caused by rupture of fatty deposits (plaque...
Show More Location
Edinburgh Heart Centre
Learn More & Join Trial
TIMES: Ticagrelor vs. Placebo/ Clopidogrel With Aspirin in Anterior STEMI Patients Treated With Primary PCI PHASE2 This is a single-centred, double blind randomized controlled trial comparin...
Show More Location
Papworth Hospital NHS Foundation Trust
Learn More & Join Trial
A Study to Compare the Safety of Rivaroxaban Versus Acetylsalicylic Acid in Addition to Either Clopidogrel or Ticagrelor Therapy in Participants With Acute Coronary Syndrome PHASE2 The purpose of this study is to estimate the risk of bleeding with rivaroxa...
Show More Location
Multiple Locations
Learn More & Join Trial
Low-dose Evaluation of Aspirin After STEMI Patients With PCI: A Multicenter, Double-blind, Randomized Controlled Clinical Trial PHASE4 The study aims to optimize the dual antiplatelet therapy regimen for patien...
Show More Location
Multiple Locations
Learn More & Join Trial
A Study Comparing Cardiovascular Effects of Ticagrelor and Clopidogrel in Patients With Peripheral Artery Disease PHASE3 The purpose of this study is to compare the effects of ticagrelor and clopi...
Show More Learn More & Join Trial
A Study to Investigate the Interaction Between ACT-246475 and Clopidogrel, Prasugrel, and Ticagrelor in Healthy Subjects PHASE1 The primary objective of this study is to assess the pharmacodynamic (PD) e...
Show More Learn More & Join Trial
Can Very Low Dose Rivaroxaban in Addition to Dual Antiplatelet Therapy (DAPT) Improve Thrombotic Status in Acute Coronray Syndrome (ACS) ACS PHASE4 A prospective, randomised, open label study of 3 clinically licensed treatm...
Show More Location
East and North Hertfordshire NHS Trust
Learn More & Join Trial
A Phase IV Study of the Onset and Maintenance of the Antiplatelet Effect of Ticagrelor Compared With Clopidogrel in Chinese Patients With ACS PHASE4 The purpose of this study is to test the hypothesis that the onset of the a...
Show More Learn More & Join Trial
The Impact of Aspirin Dose Modification on the Innate Immune Response - Will Lower Dose Aspirin Therapy Reduce the Response to Endotoxin PHASE4 Heart attacks are usually caused by clots in a coronary artery, depriving t...
Show More Location
Sheffield Teaching Hospitals NHS Foundation Trust
Learn More & Join Trial